Market Place
Sourcing Support
RetinalGenix Details Science, Mission in AI Retinal Study
14 Jan 2026 //
GLOBENEWSWIRE
RetinalgeniX Tech Hires M. Cory Zwerling As CFO, Interim COO
08 Dec 2025 //
GLOBENEWSWIRE
Retinalgenix Partners Seer Bio For Early Disease Detection
16 Oct 2025 //
GLOBENEWSWIRE
RetinalGeniX & RGEN Lab Partner To Enhance Early Detection
01 Oct 2025 //
GLOBENEWSWIRE
Retinalgenix Tech Enhances Monitoring Patents For Ocular Care
25 Sep 2025 //
GLOBENEWSWIRE
RetinalGenix partners LabCorp for DNA/GPS Platform
27 Jun 2025 //
GLOBENEWSWIRE
RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor
13 Jun 2025 //
GLOBENEWSWIRE
RetinalGenix Technologies leases lab space at MBC BioLabs
05 May 2025 //
GLOBENEWSWIRE
RetinalGenix To Join Annual Roth Conference
06 Mar 2025 //
GLOBENEWSWIRE
RetinalGenix Unveils Real-Time 24/7 Remote Ocular Monitoring Tech
20 Feb 2025 //
GLOBENEWSWIRE
RetinalGeniX Granted Patent for System For Visualization Of Ocula
22 Feb 2024 //
GLOBENEWSWIRE
RetinalGeniX Technologies Contracts With MEDsan
26 Dec 2023 //
GLOBENEWSWIRE
RetinalGeniX Appoints Anatoly Dritschilo to Company™s Medical Advisory Board
21 Dec 2023 //
GLOBENEWSWIRE
RetinalGeniX Appoints Dessy Boneva, MD, FACS to the Board of Directors
04 Dec 2023 //
GLOBENEWSWIRE
RetinalGeniX Technologies Announces Hiring of Interim CFO
01 Dec 2023 //
GLOBENEWSWIRE
RetinalGeniX Appoints Stephen Tannenbaum to Business Advisory
28 Nov 2023 //
GLOBENEWSWIRE
RetinalGeniX Contracts With Avania CRO to Provide Guidance
08 Nov 2023 //
GLOBENEWSWIRE
RetinalGeniX Technologies Focuses on Prevention of Blindness
18 Sep 2023 //
GLOBENEWSWIRE
RetinalGenix Technologies Announces the Addition of Fred
28 Aug 2023 //
GLOBENEWSWIRE
RetinalGeniX Granted Patent for Home Monitoring and Physician
28 Jul 2023 //
GLOBENEWSWIRE
Retinalgenix Expands Team to Hasten the Launch of DNA-GPS
07 Jun 2023 //
GLOBENEWSWIRE
RetinalGeniX to Present at the Emerging Growth Conference
24 Oct 2022 //
GLOBENEWSWIRE
Vinay Mehindru, Appointed to RetinalGenix Technologies Board of Directors
26 Jul 2022 //
GLOBENEWSWIRE
RetinalGeniX Technologies Acquires DNA/GPS
06 Jul 2022 //
GLOBENEWSWIRE
RetinalGeniX Has Engaged New York Investor Relations Firm
15 Dec 2020 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.